Blood biomarkers in TGF-β pathway identify hidden liver cancer risk

A new research paper was published in Genes & Cancer on February 5, 2023, entitled, “Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis.”

Opinion | When Screening Guidelines Collide, Who Wins?

Shaukat is a practicing gastroenterologist and researcher in colon cancer screening. Normally, I like titles of articles to tell me what the conclusion is. But

September 27, 2023

Dementia Risk From Midlife Onward Predicted With New Tool

A novel 14-year risk score helped identify people from age 50 onward at risk for all-cause dementia, a large U.K. study showed. The tool, called

August 25, 2023

Real world data highlights effectiveness of RSV vaccine

A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV — short for

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.